Search Results - "proteomics"
Suggested Topics within your search.
Suggested Topics within your search.
- diagnosis
- Biochemical markers 11
- Biomarkers 11
- Methodology 11
- Proteomics 11
- methods 11
- Cancer 5
- Cardiovascular Diseases 5
- Diagnosis 5
- analysis 5
- Alzheimer Disease 3
- Alzheimer's disease 3
- Bladder 3
- Cardiovascular system 3
- Computational Biology 3
- Degeneration 3
- Diseases 3
- Genetics 3
- Neoplasm Recurrence, Local 3
- Neoplasms 3
- Nervous system 3
- Neurodegenerative Diseases 3
- Ovarian Neoplasms 3
- Proteome 3
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 3
- Variation (Genetics) 3
- physiopathology 3
- Analysis 2
- DNA 2
- Heart Disease Risk Factors 2
-
1
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
2
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
3
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
4
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
5
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
6
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
7
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
8
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
9
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
10
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
11
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
12
Diagnosis of early relapse in ovarian cancer using serum proteomic profiling
Published 2007Get full text
Series
Electronic Video -
13
Diagnosis of early relapse in ovarian cancer using serum proteomic profiling
Published 2007Get full text
Series
Electronic Video -
14
Diagnosis of early relapse in ovarian cancer using serum proteomic profiling
Published 2007Get full text
Series
Electronic Video